MFSD7 Activators
Y-27632 is a selective inhibitor of Rho-associated protein kinase (ROCK), which plays a significant role in regulating the shape and movement of cells through the actin cytoskeleton. By inhibiting ROCK, Y-27632 may lead to changes in cell morphology and motility, which could indirectly affect the trafficking and function of membrane proteins including MFSD7. For example, if MFSD7 trafficking to the plasma membrane is actin-dependent, modulation of the cytoskeleton could enhance its cell surface expression and activity.
PMA (Phorbol 12-myristate 13-acetate) is a potent activator of protein kinase C (PKC), a family of protein kinases involved in controlling the function of other proteins through the phosphorylation of hydroxyl groups of serine and threonine amino acid residues. Activation of PKC has been implicated in regulating a vast array of cellular functions, including transporter and channel activities. By activating PKC, PMA might enhance the phosphorylation state of MFSD7, which could affect its activity, trafficking, or cell surface stability.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) acts as a non-selective inhibitor of phosphodiesterases, thereby preventing the breakdown of cAMP and cGMP. This leads to increased levels of these cyclic nucleotides within the cell, which may indirectly enhance MFSD7 activity by promoting signaling pathways regulated by cAMP and cGMP. | ||||||
VU0359595 | 1246303-14-9 | sc-475843 | 5 mg | $190.00 | 1 | |
VU0359595 is an allosteric activator of the M1 muscarinic acetylcholine receptor. Activation of M1 receptor can lead to enhanced intracellular calcium levels and activation of calcium-dependent signaling pathways, which may indirectly enhance the activity of MFSD7 by affecting calcium-regulated transporters or channels. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can influence signaling pathways by preventing phosphorylation of key proteins. By modulating these pathways, genistein may indirectly increase the activity of MFSD7 by affecting signaling cascades that regulate transporter function or localization. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/Akt signaling pathway. This alteration may influence MFSD7 activity by affecting membrane trafficking or transporter regulation that is PI3K/Akt-dependent. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, which may lead to changes in the actin cytoskeleton. Such changes can affect cellular transport mechanisms, potentially enhancing the activity of MFSD7 through altered membrane dynamics and trafficking. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in a wide range of signaling pathways. PKC activation can lead to phosphorylation events that enhance the functional activity of transporters and channels, potentially including MFSD7. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. This elevation in calcium can activate calcium-dependent signaling pathways, indirectly enhancing the activity of MFSD7 through calcium-sensitive regulatory mechanisms. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram selectively inhibits phosphodiesterase 4 (PDE4), leading to an accumulation of cAMP within the cell. This increase in cAMP may enhance MFSD7 activity due to the activation of cAMP-dependent pathways that could regulate transporter function. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β receptor. Inhibition of this pathway can affect cellular processes including proliferation and differentiation, which may indirectly enhance MFSD7 activity by influencing transporter expression levels or localization. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. While typically associated with inhibition, in the context of MFSD7, altering this pathway could lead to compensatory mechanisms that enhance the activity of transporters, including MFSD7. | ||||||